Pancreatic tumors reprogram immune cells that normally shut down tumor-killing cells, according to a team at Oregon Health & ...

Scientists caution that more research is needed, but nearly all of the patients who responded to the personalized vaccine are ...

After nearly 100 years of development, treatments that bolster the body's immune system to fight cancer are coming of age – ...

Dipika Kakar faced a health setback months after her liver cancer treatment. She had to be hospitalised for a cyst removal in ...

Fred Hutch Cancer Center molecular biologist Dr. Kevin Barry just received a $270,000, two-year grant from the American ...

A healthy thymus in adults is tied to longer life, reduced disease risk, and improved cancer treatment response.

Researchers at Oregon Health & Science University have uncovered a key reason why immunotherapy has largely failed in ...

The specific mix of bacteria living in a person's gut can predict the chances that melanoma will recur after surgery and ...

Immunotherapy is generally associated with fewer and milder side effects compared to chemotherapy. Many patients are able to ...

The Parker Institute for Cancer Immunotherapy (PICI), today announced that research and expertise from across its network ...

Multiple myeloma research led by researchers at the University of Calgary identified how tumor cells adapt after ...

Multiple myeloma is the second most common blood cancer in adults. It starts in the white blood cells that are responsible ...